Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.71 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.42 |
| ▸ | GABRP | O00591 | 2/20 | 0.41 |
| ▸ | GABRD | O14764 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.41 |
| ▸ | GABRE | P78334 | 2/20 | 0.41 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49007 | 1.00 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL8892964 | 1.00 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL10922365 | 1.00 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL7734724 | 1.00 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL1012485 | 0.96 | OPRM1 (0.75) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL19395998 | 0.90 | OPRM1 (0.60) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL14006779 | 0.90 | OPRM1 (0.60) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL22474102 | 0.90 | OPRM1 (0.60) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL21142889 | 0.90 | OPRM1 (0.60) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL22221856 | 0.90 | OPRM1 (0.60) | OPRM1TP53TRPV1TRPA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023072992-A1 | MANNICH BASE WITH HIGH CONTENT IN RENEWABLE CARBON | SIKA TECHNOLOGY AG (CH) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023077162-A2 | METHODS TO QUANTIFY AFFINITY AND SELECTIVITY OF COMPOUNDS FOR PROTEINS IN LIVING CELLS | OHIO STATE INNOVATION FOUNDATION (US) | 2023-05-04 | — | — | WO | disclosed |
| CN-110121497-A | Amidine catalyst for curable compositions | SIKA技术股份公司 | 2019-08-13 | — | — | CN | disclosed |
| US-10364210-B2 | Diamine compounds, dinitro compounds and other compounds, and methods of producing thereof and uses related thereof | MICROMIDAS, INC. (US) | 2019-07-30 | — | — | US | disclosed |
| US-20170275236-A1 | DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF | MICROMIDAS, INC. (US) | 2017-09-28 | — | — | US | disclosed |
| CN-104039859-B | Hydroxyl amino polymer and preparation method thereof | 科思创德国股份有限公司 | 2017-03-01 | — | — | CN | disclosed |
| WO-2016033348-A1 | DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF | MICROMIDAS, INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| US-5610141-A | CELL DIVISION STIMULANT | NYCOMED IMAGING AS (NO) | 1997-03-11 | — | — | US | disclosed |
| WO-1993024523-A1 | DOUBLE CHAIN PEPTIDE COMPOUNDS HAVING HEMOREGULATORY ACTIVITY | HAFSLUND NYCOMED AS (NO) | 1993-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275236-A1 | DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF | DDC, DDT, DAO | OPRM1 2304/4885TP53 2074/4885TRPV1 623/4885 |
| US-10364210-B2 | Diamine compounds, dinitro compounds and other compounds, and methods of producing thereof and uses related thereof | DDC, DDT, DAO | OPRM1 2304/4885TP53 2074/4885TRPV1 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.